Position in MRK
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$2,370,054
+$147,576 QoQ
Shares Held
18,444
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#1,485
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Avestar Capital, LLC holds $29,224,901 across 12 Drug Manufacturers - General names. MRK ranks #5 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,456 | $10,142,380 | |
| 2 | JNJ |
Johnson & Johnson
|
18,732 | $4,757,366 | |
| 3 | ABBV |
AbbVie Inc.
|
14,349 | $3,610,782 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
20,418 | $2,579,610 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
18,444 | $2,370,054 | |
| 6 | AZN |
Astrazeneca PLC
|
6,836 | $1,296,242 | |
| 7 | AMGN |
Amgen Inc
|
3,577 | $1,295,303 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,003 | $922,092 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,370,054 | 18,444 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $2,222,478 | 18,476 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,843,944 | 17,518 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,630,843 | 19,431 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,330,917 | 16,813 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,243,983 | 13,859 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,852,417 | 18,621 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $2,050,552 | 18,057 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,357,523 | 19,043 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,810,749 | 13,723 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,192,133 | 10,935 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $896,591 | 8,709 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $849,270 | 7,360 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $721,430 | 6,781 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $736,264 | 6,636 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $527,829 | 6,129 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $392,304 | 4,303 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $287,749 | 3,507 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $223,635 | 2,918 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $213,838 | 2,847 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $209,745 | 2,697 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $205,290 | 2,663 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $209,162 | 2,557 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $307,827 | 3,711 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $281,017 | 3,634 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $257,364 | 3,345 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||